Innovative Heart Monitoring Company with Significant International Market Potential

This listing represents a publicly traded US company specializing in innovative ambulatory non-invasive cardiac monitoring solutions. The company offers FDA and CE cleared EKG devices, coupled with interactive cloud-based acquisition software and smartphone applications for iOS and Android. These products aim to enhance patient compliance and provide physicians with more accurate diagnostic information. The business has identified a substantial international market opportunity, particularly in China, with significant projected revenues for 2025 and 2026. The US market is also poised for expansion. The company is seeking growth capital to achieve its planned objectives, offering flexible deal terms to accredited investors. Profit margins are noted as very significant.